Drug Shortage Report for TEVA-ZOPICLONE

Last updated on 2022-12-15 History
Report ID 124110
Drug Identification Number 02242481
Brand name TEVA-ZOPICLONE
Common or Proper name ZOPICLONE 7.5MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ZOPICLONE
Strength(s) 7.5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code N05CF
ATC description HYPNOTICS AND SEDATIVES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-09-10
Estimated end date 2022-12-20
Actual end date 2022-12-14
Shortage status Resolved
Updated date 2022-12-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v32 2022-06-09 French Compare
v31 2022-06-09 English Compare
v30 2022-05-05 French Compare
v29 2022-05-05 English Compare
v28 2022-04-21 French Compare
v27 2022-04-21 English Compare
v26 2022-03-09 French Compare
v25 2022-03-09 English Compare
v24 2021-12-22 French Compare
v23 2021-12-22 English Compare
v22 2021-11-25 French Compare
v21 2021-11-25 English Compare
v20 2021-11-04 French Compare
v19 2021-11-04 English Compare
v18 2021-09-30 French Compare
v17 2021-09-30 English Compare
v16 2021-08-13 French Compare
v15 2021-08-13 English Compare
v14 2021-07-15 French Compare
v13 2021-07-15 English Compare

Showing 21 to 40 of 52